BioXcel Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: BioXcel Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: BioXcel Therapeutics Inc
Rating: 0.81675
Author: Trendlyne DVM scores

about

BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeli...

1.82 0.01 (0.55%)

77.48% Fall from 52W High

390.3K

XNAS Volume

XNAS 23 Jan, 2026 4:30 PM (EST)

Not Eligible

Expensive Valuation

3.5 / 100

Technically Bearish

29.2 / 100

1Yr Price target upside is 820%

4 analysts

BioXcel Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

BioXcel Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeli...

77.48% Fall from 52W High

SWOT Analysis

BioXcel Therapeutics Inc Live Price Chart